[AT1-blockers in the treatment of hypertension: summary]

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Hypertension Management

Background:

• Angiotensin receptor antagonists (AT(1)-blockers) are a significant class of antihypertensive medications.
• These drugs are suitable for both monotherapy and combination treatment regimens.
• Current hypertension guidelines recognize AT(1)-blockers as a universal drug class.

Purpose of the Study:

• To review the antihypertensive efficacy of AT(1)-blockers.
• To discuss their safety and tolerability profile compared to other drug classes.
• To explore their role in current hypertension treatment guidelines and clinical practice.

Main Methods:

• Literature review of clinical trials and guidelines.
• Analysis of comparative efficacy and safety data.
• Discussion of pharmacological mechanisms and therapeutic indications.

Main Results:

• AT(1)-blockers demonstrate comparable antihypertensive efficacy to other major drug classes.
• They possess the most favorable side-effect profile among antihypertensive agents, promoting high therapy persistence.
• Guidelines classify them as a universal antihypertensive option.

Conclusions:

• AT(1)-blockers are a well-established and highly tolerable class of antihypertensive drugs.
• Their efficacy, safety, and guideline recommendations support their widespread use in managing hypertension.
• High persistence due to a low side-effect profile enhances long-term treatment success.